Capricor Therapeutics, Inc.

Ticker CAPR

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Los Angeles, California

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor鈥檚 lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and…More

REPORT RATINGS

4.8 / 5.0 (240)

Capricor Therapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 240 reviews.

Capricor Therapeutics, Inc.